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Abstract
Background: In many cells, bile acids (BAs) have a multitude of effects, some of which may be mediated by specific
receptors such the TGR5 or FXR receptors. In pancreas systemic BAs, as well as intra-ductal BAs from bile reflux, can
affect pancreatic secretion. Extracellular ATP and purinergic signalling are other important regulators of similar secretory
mechanisms in pancreas. The aim of our study was to elucidate whether there is interplay between ATP and BA signalling.
Results: Here we show that CDCA (chenodeoxycholic acid) caused fast and concentration-dependent ATP release from
acini (AR42J) and duct cells (Capan-1). Taurine and glycine conjugated forms of CDCA had smaller effects on ATP
release in Capan-1 cells. In duct monolayers, CDCA stimulated ATP release mainly from the luminal membrane; the
releasing mechanisms involved both vesicular and non-vesicular secretion pathways. Duct cells were not depleted of
intracellular ATP with CDCA, but acinar cells lost some ATP, as detected by several methods including ATP sensor
AT1.03YEMK. In duct cells, CDCA caused reversible increase in the intracellular Ca2+ concentration [Ca2 +]i, which could
be significantly inhibited by antagonists of purinergic receptors. The TGR5 receptor, expressed on the luminal side of
pancreatic ducts, was not involved in ATP release and Ca2+ signals, but could stimulate Na+/Ca2+ exchange in
some conditions.
Conclusions: CDCA evokes significant ATP release that can stimulate purinergic receptors, which in turn increase
[Ca2+]i. The TGR5 receptor is not involved in these processes but can play a protective role at high intracellular
Ca2+ conditions. We propose that purinergic signalling could be taken into consideration in other cells/organs,
and thereby potentially explain some of the multifaceted effects of BAs.
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Lay abstract
In recent years there has been a growing interest for the role
of bile acids as signalling molecules in many cells/organs.
Several types of bile acids receptors have been identified,
but some modulatory functions of bile acids remain unex-
plained. Here, we show that bile acids, in particular cheno-
deoxycholic acid, causes significant release of ATP from
exocrine pancreatic cells. Extracellular ATP can then via
purinergic receptors regulate or co-regulate epithelial func-
tions, such as pancreatic duct secretion, which is important
for normal digestive processes. Our study brings novel
insights into regulation of pancreas functions. Moreover,
we propose that purinergic signalling should be taken into
consideration in other cells/organ types, as it could poten-
tially explain some of the multifaceted effects of bile acids.
Background
Bile acids (BAs) are natural amphiphilic metabolites ori-
ginating from cholesterol degradation. The main human
primary bile acids are chenodeoxycholic acid (CDCA) and
cholic acid (CA), which can be conjugated with glycine
and taurine to form bile salts. The role of bile acids as sig-
nalling molecules and as targets for drug development
gained interest during the last years, and several bile acid
receptors were discovered, including the nuclear farnesoid
receptor (FXR) and the membrane receptor TGR5
(GPBAR1) [1–4]. TGR5 is expressed in many cell types
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and regulates a variety of functions. For example, TGR5
modulates liver function, glucose metabolism and insulin
sensitivity, and immune responses [4–7]. In several epi-
thelia such as colon, respiratory epithelia and bile ducts,
BAs regulate ion transport, at least partly via TGR5 or
FXR receptors [8–10]. For example, in bile ducts, TGR5
stimulates biliary HCO3
− and fluid secretion [11–14].
In pancreas, BAs have multiple effects. In the endocrine
pancreas, tauroursodeoxycholate has a protective role on
pancreatic islets as it decreases apoptosis and stimulates in-
sulin secretion after stress conditions [15]. It is reported
that BAs can stimulate both FXR and TGR5 receptors in
mouse β-cells and induce fast insulin secretion [16, 17].
Furthermore, there is TGR5-dependent stimulation of
glucagon-like-peptide-1 (GLP-1) release from enterocytes
[18], and then systemic GLP-1 increases insulin secretion
from β-cells [19]. In exocrine pancreas, BAs can exert ef-
fects on several levels, as they can reach pancreas not only
systemically, but also via reflux of bile into pancreatic ducts.
Pancreatic acini express BA transporters [20] and some
BAs at low concentrations can activate Ca2+-independent
cation currents [21]. At high concentrations BAs can evoke
cytotoxicaly high intracellular Ca2+ concentrations, [Ca2+]i,
in pancreatic acini. This is due to inhibition of the sacro/
endoplasmatic reticulum Ca2+-ATPases (SERCA), release
of Ca2+ from ER and acidic stores and granules, increased
Ca2+ influx, and acini show cellular acidosis, enzyme acti-
vation and mitochondrial malfunction, which can even-
tually lead to development of (biliary) acute pancreatitis
[20, 22–24]. In one study, TGR5/GPBAR1 receptor
knockout mice had less severe pancreatitis after infu-
sion of BAs [25]. For pancreatic ducts, it has been pro-
posed that BAs can stimulate duct secretion and they
can tolerate higher BA concentrations [26–28]. Several
studies show that BAs stimulate Cl− and K+ channels;
where the later have been identified as large conductance
Ca2+-activated K+ channels (BK, KCa1.1), but identity of
Cl− channels is not clear [26, 29, 30].
Another important regulatory system in pancreatic
ducts is the purinergic signalling. Extracellular ATP
can, via a number of P2 receptors that stimulate Ca2+
signalling, regulate Cl− and K+ channels and acid/base
transporters and thereby modulate HCO3
− and fluid se-
cretion [31, 32]. Until now it has not been investigated
whether pancreatic ducts release ATP, however, it is
well established that ATP is released from pancreatic
acini, which store ATP in zymogen granules, where it is
accumulated by the Vesicular NUcleotide Transporter
(VNUT, SLC17A9) [33]. Acinar ATP is released by exo-
cytosis into the duct lumen in response to cholinergic
or hormonal stimulation [34, 35]. In various other cells,
ATP release can occur also via ion channels/transporters,
such as maxi-anion channels, connexins, pannexins with/
without P2X7 receptors [36, 37].
Considering that BAs and purinergic signalling appear
to have similar paracrine effects on ion and fluid transport
in exocrine pancreas, we hypothesized whether there was
any interaction between these two intra-ductal regulatory
systems. Therefore, we designed a study to test whether
BAs, i.e., chenodeoxycholic acid (CDCA) and its glycine
and taurine conjugated forms (GCDCA and TCDCA) can
affect ATP release, and whether CDCA also influence
intracellular ATP levels. A further aim was to elucidate
whether BA signalling involves TGR5 or FXR receptors in
the ATP release process and/or P2 receptors and down-
stream Ca2+ signalling. For this purpose we used duct and
acini models (Capan-1 and AR42J cells), live cell lumi-
nescence assay for extracellular ATP, intracellular ATP
sensors, AT1.03YEMK, and [Ca2+]i. imaging. Our study
shows that CDCA indeed caused a very fast release of
ATP from exocrine pancreatic cells via both non-
exocytotic and vesicular pathways. Furthermore, a sig-
nificant part of the CDCA effect on Ca2+ signalling is
mediated via purinergic signalling. We also demonstrate
the presence of the TGR5 and FXR receptors in human
pancreatic ducts and show that TGR5 receptor can pre-
vent intracellular Ca2+ overloads possibly by stimulation
of the Na+/Ca2+ exchanger.
Results
CDCA but not GCDCA and TCDCA stimulates high ATP
release from pancreatic cells
ATP release on the whole organ level is difficult to detect
due to action of membrane-bound and soluble nucleotid-
ases [35, 38]. Therefore, ATP release and autocrine/para-
crine signalling is usually studied on isolated cells or cell
lines. In the first series of experiments we investigated the
effect of several bile acids: GCDCA (glycochenodeoxy-
cholic acid); TCDCA (taurochenodeoxycholic acid); and
CDCA (chenodeoxycholic acid) on ATP release from
Capan-1 cells, which are a model of pancreatic ducts.
Time resolved luminescence recordings revealed that
0.3 mM of GCDCA and TCDCA had minor effects on
ATP release from these cells (Fig. 1 a-b). At higher con-
centrations (1 mM) GCDCA evoked significant but
small increase in extracellular ATP, ATPe, by 4.2 ± 0.8
nM (n = 4) above the basal level. TCDCA (1 mM) had
no effect on ATP release. In contrast to GCDCA and
TCDCA, CDCA (0.3 mM) caused a fast and substantial
ATP release in Capan-1 cells (Fig. 1c). Therefore, we in-
vestigated the effect of CDCA concentrations on ATP
release from Capan-1 (Fig. 1d). Furthermore, we investi-
gated the effect of CDCA on AR42J cells, which are a
model for pancreatic acinar cells (Fig. 1 e, f). Fig. 1 c-f
shows that the duct and acinar cells released ATP in a
concentration-dependent manner in a narrow range from
0.1 to 1 mM CDCA, and EC50 values are 0.43 mM and
0.44 mM for Capan-1 and AR42J cells, respectively. The
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peak/maximum ATP release observed after stimulation
with 1 mM CDCA was 848 ± 16 nM (n = 6) for Capan-1
and 614 ± 79 nM (n = 5) for AR42J cells. These data show
that CDCA can increase extracellular ATP concentrations
by a factor of 100–1000 above the baseline. In all the fol-
lowing experiments, Capan-1 cells were stimulated with
0.3 mM CDCA and AR42J cells with 0.5 mM CDCA.
Since Capan-1 cells are a model of human pancreatic
duct epithelium, it was relevant to investigate whether
ATP release is polarized, i.e., whether it occurs preferen-
tially across the luminal or the basolateral membrane.
Capan-1 cells were cultured as polarized monolayers, and
CDCA was administered luminally or basolaterally. After
the luminal stimulation with 0.3 mM CDCA (Fig. 2a),
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Fig. 1 CDCA induced ATP release from exocrine pancreatic cells. The time-course of ATP release from Capan-1 cells in response to 0.3 and 1 mM
of (a) GCDCA and (b) TCDCA (n = 4, 4). The time-course of ATP release from (c) Capan-1 and (e) AR42J after stimulation with 0.3 and 0.5 mM
CDCA, respectively (n = 6, 5). Dose-dependent release of ATP from (d) Capan-1 and (f) AR42J cells in response to CDCA (n = 5, 6). The EC50 values
of ATP release from AR42J and Capan-1 are 0.44 mM (pEC50 = 3.36 ± 0.03) and 0.43 mM (pEC50 3.36 ± 0.04) (n = 5, 6) respectively in the range of
0.1 – 1 mM CDCA. Y-axis shows ATP concentrations, which were corrected for 106 cells per 1 ml (see Methods). Data shown as mean values ±
SEM. Arrows indicate addition of stimulants
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there was significantly higher ATP release from the
luminal side (5.7 ± 1.3 nM, n = 8) compared to the baso-
lateral side (1.3 ± 0.7 nM, n = 5). Interestingly, a similar
high luminal ATP release was observed when mono-
layers were stimulated with basolateral CDCA (Fig. 2a).
ATP released across the luminal side was 10.5 ± 2.9 nM
(n = 3) compared to the basolateral side 0.6 ± 0.03 nM
(n = 5). Notably, these ATP values made in offline ana-
lysis of samples were lower than in online measure-
ments, most likely due to different sampling volumes
and ATP hydrolysis by ecto-nucleotidases [39, 40].
CDCA induces ATP release via multiple pathways
In order to identify the pathways involved in CDCA-
induced ATP release, Capan-1 cells were incubated with
vesicular and non-vesicular transport inhibitors. Fig. 2b
shows that CDCA caused high ATP release of 100 ± 10
nM (n = 8), and after incubation with bafilomycin A1, an
inhibitor for vacuolar-type H+-ATPase, ATP release was
significantly reduced to 61 ± 12 nM (n = 5). Inhibition of
CDCA-evoked vesicular ATP release was also observed
in the presence of N-Ethylmaleimide, an inhibitor of
vesicle fusion, which markedly supressed ATP release to
9 ± 3 nM (n = 4). In addition, reducing vesicular trans-
port from ER to Golgi by brefeldin A also decreased the
ATP release to 55 ± 11 nM (n = 8). In another series of
experiments, we tested the effect of non-vesicular trans-
port inhibitors (Fig. 2c). Data presented in Fig. 2c, show
that Gd3+, which inhibits pannexin and connexin hemi-
channels in addition to maxi anion channels, markedly
inhibited CDCA-induced ATP release to 8 ± 4 nM (n = 6)
compared to control of 76 ± 15 nM (n = 10). When cells
were treated with probenecid, there was a significant
decrease in ATP release to 24 ± 9 nM (n = 7). The
pannexin-1 inhibitor, 10Panx, tended to decrease ATP
release to 47 ± 15 nM (n = 7), but no statistical signifi-
cance was reached. Two P2X7 receptor antagonists
significantly inhibited the ATP release to 19 ± 5 nM
(AZ10606120, n = 9) and 25 ± 5 nM (A438079, n = 8).
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Fig. 2 Sidedness of ATP release and the effect of vesicular and
non-vesicular inhibitors on ATP release pathways. a Mean values of
ATP released across basolateral (BL) and luminal (L) sides from Capan-1
cells after 1 min of apical or serosal stimulation with 0.3 mM CDCA. b
Inhibitors of vesicular transport decreased ATP release from Capan-1
cells in response to 0.3 mM CDCA. Cells were incubated with
vacuolar-type H+-ATPase inhibitor (bafilomycin A1, 1 μM; n = 5),
vesicle fusion inhibitor N-Ethylmaleimide (NEM, 250 μM, n = 4) and
brefeldin A (5 μg/ml; n = 8). c Influence of the non-vesicular transport
inhibitors: gadolinium chloride (Gd3+, 50 μM; n = 6), probenecid
(500 μM; n = 7), 10Panx - mimetic pannexin peptide (100 μM; n = 7), as
well as P2X7 receptor inhibitors AZ10606120 (10 μM; n = 9) and
A438079 (10 μM; n = 7) on CDCA-induced ATP release from Capan-1
cells is shown. Results are given as mean net values ± SEM. *= P < 0.05,
**= P < 0.01, ***= P < 0.001
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Taken together, present data indicate that both vesicular
and non-vesicular mechanisms are involved in CDCA-
induced ATP release from pancreatic epithelial cells.
Effect of CDCA on intracellular ATP
Since we observed that CDCA stimulated substantial ATP
release from exocrine pancreatic cells, in the following ex-
periments we investigated whether this was accompanied
by a decrease of intracellular ATP concentrations, ATPi.
We used the Magnesium Green (MgGreen), an indirect
ATP sensor, as it increases in fluorescence when ATP con-
centrations decrease and the released Mg2+ can bind to
the fluorophore. After CDCA stimulation, there was a fast
and transient increase in the MgGreen F/F0 fluorescence
ratio to 1.53 ± 0.21 in AR42J (n = 3), and then the ratio de-
creased but remained elevated by about 0.2 units above
the basal value (Fig. 3a). Capan-1 cells also responded by a
transient increase in F/F0 ratio to 1.34 ± 0.08 (n = 6), but
after 300–400 s the signal recovered to pre-CDCA values
(Fig. 3b). The transient changes in MgGreen fluorescence
could have several explanations (see Discussion). Since we
observed a tendency to partial depletion of ATPi in AR42J
cells after prolonged stimulation with CDCA (Fig. 3a), we
used a more direct method employing one of the ATeam
sensors developed by Imamura and colleagues [41].
AR42J cells were transfected with AT1.03YEMK and
simultaneous images of YFP and CFP were used to build
YFP/CFP ratio. Fig. 4a shows that there was a small de-
crease in the ratio with CDCA incubation, which indicates
decreased FRET. In addition, in separate fluorescence
lifetime imaging (FLIM) experiments we determined CFP
fluorescence lifetime of AT1.03YEMK using the time-
correlated single-photon counting technique. The data
were used to generate a lifetime map by fitting each point
to a double exponential decay. χ2 values were lying around
0.9-1.1. The sensor had a uniform lifetime distribution
within the cell cytoplasm (Fig. 4b). It is well established
that CFP has bi-exponential decay and the reported life-
times lie around 1.1–1.3 ns and 2.8–2.9 ns [42]. For
untreated AR42J cells we found two lifetimes of 0.876 ±
0.013 ns and 2.732 ± 0.026 ns (n = 25). These lifetimes
were shorter than the reported lifetime for CFP due to fact
that the interacting donor lifetime is shortened by ATP
binding and causing FRET in the AT1.03YEMK sensor.
After addition of CDCA the lifetimes increased to 0.950 ±
0.018 and 2.815 ± 0.033 in the same experiments, indicat-
ing that there is less FRET, likely corresponding to less
ATP within the cell.
The above ATPi measurement methods are dynamic,
but difficult to calibrate in acinar cells. Therefore, we also
used luciferin/luciferase assay to determine ATPi. Cell
membranes were permeabilized with digitonin after
CDCA treatment and intracellular ATPi was quantified
(Fig. 5a). ATPi concentrations were measured at different
time points (1 and 12 min), correlating with the peak and
plateau for MgGreen (Fig. 3). Additionally, the long-term
effect was also determined by incubating the cells with
CDCA for 24 h. After stimulation with 0.3 mM CDCA,
Capan-1 released 68 ± 26 nM ATP to extracellular
medium, which corresponds to a calculated decrease of
0.08 ± 0.03 mM ATPi in a cell (n = 8). Fig. 5b shows that
after incubation of duct cells for 1 min and 12 min, the
total content of remaining ATPi was not significantly
changed and remained at 2.47 ± 0.32 mM calculated per
cell; (n = 8) and 2.22 ± 0.5 mM (n = 7) compared to their
respect controls of 2.72 ± 0.38 mM and 2.46 ± 0.45 mM
(n = 7). Furthermore, the long-term exposure of Capan-1
to 0.3 mM CDCA did not cause significant changes in
ATPi concentrations, i.e., 2.08 ± 0.24 mM compared
to control 1.85 ± 0.18 mM (n = 10). For AR42J cells,
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Fig. 3 CDCA effect on Magnesium Green fluorescence in AR42J and
Capan-1. Effect of 0.5 and 0.3 mM CDCA on intracellular ATP (ATPi)
changes in AR42J (a) (n = 3) and Capan-1 (b) (n = 4) cells. Cells were
loaded with Magnesium Green indicator (5 μM) for 20 min. Changes
of ATPi are given as ratios of fluorescence at time t in relation to
time 0 (Ft/F0), where the starting baseline is set to the 1. Results are
shown as mean values ± SEM of 10 cells or group of acini per each
individual experiment. Arrows indicate time of adding CDCA
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stimulation with 0.5 mM CDCA (Fig. 5c) caused ATP
release of 358 ± 52 nM to extracellular medium, which
corresponds to a calculated decrease of 0.68 ± 0.1 mM
in the cell (n = 5). Similar to the Capan-1 cells, we did not
observe significant changes in remaining ATPi concentra-
tions after 1 min (1.36 ± 0.1 mM; n = 5). However, after
12 min there was a tendency, though not significant, of
lower intracellular ATP levels (0.68 ± 0.06 mM; n = 5) with
CDCA compared to their respective controls (1.12 ±
0.01 mM and 0.97 ± 0.13 mM; n = 5). Furthermore, after
24 h incubation of AR42J with 0.5 mM CDCA, there was
a significant decrease of ATPi to 0.66 ± 0.06 mM com-
pared to the control 1.3 ± 0.08 mM (n = 10).
CDCA-induced intracellular Ca2+ responses are inhibited
by P2 receptor inhibitors
Bile acids are reported to increase [Ca2+]i in pancreatic
cells, but it is not clear which receptors are involved (see
Introduction). Since we observed that CDCA induced
ATP release, we hypothesized that the intracellular Ca2+
responses could be due to effect of released ATP on P2
receptors, which are well established regulators of stimu-
lated Ca2+ influx and/or Ca2+ release in pancreatic ducts.
Therefore, [Ca2+]i was monitored in Capan-1 cells in a
chamber perfused with physiological solution containing
CDCA followed by ATP (Fig. 6a,c). CDCA evoked a
slow Δ[Ca2+]i increase (180 ± 24 nM, n = 5). Similar slow
and small responses to other BAs were also reported for
pancreatic acinar cells and cholangiocytes [25, 43]. In
contrast, infusion of ATP caused fast and markedly
higher Δ[Ca2+]i increase (772 ± 173 nM, n = 5). Further
experiments were conducted without perfusion, in order
to minimize mechanical stimulation and amount of in-
hibitors used. In standing bath CDCA evoked similar
Δ[Ca2+]i response as in the perfused conditions, but the
signal was delayed (Fig. 6b, d). Stimulation with ATP in
the presence of CDCA, caused a lower but fast Δ[Ca2+]i
response (302 ± 47 nM, n = 4), perhaps because P2 re-
ceptors were already desensitized by CDCA-induced
ATP release as ATP was not washed away during perfu-
sion. Therefore, for the following studies with P2R inhib-
itors, we conducted separate experiments for the ATP
and CDCA stimuli.
Figure 7a-d shows that the P2R inhibitors markedly re-
duced the ATP-stimulated Δ[Ca2+]i response from 937 ±
88 nM (n = 11) to 232 ± 47 nM (n = 9). The antagonists
also caused significant inhibition of CDCA stimulated
Δ[Ca2+]i (from 217 ± 54 to 90 ± 9 nM; n = 5). These data
indicate that the Δ[Ca2+]i response evoked by the bile
acid could be a result of P2 receptor stimulation by
CDCA-induced ATP release. Thapsigargin, the inhibitor
of SERCA [44], was added at the end of the experiments
to inhibit re-uptake of Ca2+ to intracellular stores. Thap-
sigargin induced a small Δ[Ca2+]i increase after CDCA
by 70 ± 17 nM (n = 5) but a large increase after ATP, i.e.,
971 ± 143 nM, (n = 6). P2R inhibitors did not have effect
on intracellular Ca2+ response induced by thapsigargin
after ATP (Fig. 7c). Interestingly, when thapsigargin was
applied after CDCA in the presence of the P2R inhibi-
tors (Fig. 7d), Δ[Ca2+]i was significantly higher (270 ± 35
nM, n = 5).
Expression of the TGR5 and FXR receptors in exocrine
pancreatic cells
It is not known whether TGR5 and FXR receptors are
expressed in the human pancreatic ducts and could ac-
count for the effects seen in our study. Also from studies
on animal pancreatic tissue, it is not certain whether
TGR5 is expressed in ducts [25, 29]. We therefore inves-
tigated TGR5 expression in AR42J and Capan-1 cells
using RT-PCR and Western Blot. Fig. 8a, b shows that
TGR5 is expressed in both cell lines. This observation
was confirmed by immunostaining of the acinar cells
and on a polarized monolayer of Capan-1 (Fig. 8c, d). In
duct epithelium it appears that the receptor is localized
mainly on the luminal membrane. Since TGR5 is
expressed in pancreatic cells, we wanted to determine
whether the receptor has any effect on ATP release and
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for this purpose we used GPBAR-A, a specific TGR5
receptor agonist that upon binding stimulates cAMP
synthesis [45]. Using the luminescence method, we did
not detect ATP release (Fig. 8e) from Capan-1 cells after
stimulation with 3 or 30 μM GPBAR-A.
In another series of experiments we investigated
whether Capan-1 cells express the nuclear type of bile
acid receptor, FXR, and whether its stimulation might
induce ATP release. We indeed found the transcript for
FXR in Capan-1 cells using RT-PCR (Fig. 8f ). However,
activation of the receptor with the specific agonist
GW4064 (0.1 and 1 μM) did not cause significant ATP
release (Fig. 8f ). Based on these observations, we con-
cluded that stimulation of BAs receptors TGR5 and
FXR with specific pharmacological agonists does not in-
duce ATP release from duct cells.
Above we observed that CDCA appeared to protect
Capan-1 cells from thapsigargin effects (Fig. 7d, f ). This
could occur if, for example, CDCA stimulated SERCA
(or protected the pumps from thapsigargin) or if CDCA
stimulated alternative Ca2+ efflux pathways. Our hypoth-
esis was that the TGR5 receptor could be involved in
these effects and we tested this in the following experi-
ments. First, intracellular Ca2+ stores were emptied by
thapsigargin in low Ca2+ medium (Fig. 9a). Thereafter,
extracellular Ca2+ was reintroduced, and since SERCA
pumps were inhibited, [Ca2+]i increased to very high
levels in control cells. Notably, perfusion of the cells with
CDCA caused a fast and marked reduction in [Ca2+]i from
1253 ± 117 to 244 ± 28 nM (Fig. 9 a, b, n = 3). A similar
response was observed with perfusion of GPBAR-A
(Fig. 9a-b), which lowered the [Ca2+]i from 1249 ± 69
nM to 647 ± 71 nM (n = 5).
In next experiments we addressed the question whether
the lowering of [Ca2+]i caused by CDCA could involve
Ca2+ efflux via the Na+/Ca2+ exchanger (NCX), which is
expressed in duct epithelia [46, 47]. Since CDCA evokes
Ca2+ transients itself, we used, GPBAR-A, which
showed no effect on Ca2+ responses when given alone
(see Additional file 1: Figure S1). Capan-1 cells were
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Fig. 5 The acute and chronic effects of CDCA on intracellular ATP
concentration in AR42J and Capan-1 cells. a Original trace for
luminometric measurements of ATP based on Capan-1 measurement.
Baseline values were recorded every 20 s for 2 min. Cells were then
stimulated with 0.3 mM (Capan-1) or 0.5 mM (AR42J) with CDCA or
with vehicle. Stimulated ATP release was recorded every 1 sec for
1 min directly after addition of CDCA, or after 12 min or 24 h of
incubation. Finally, cells were permeabilized with digitonin (50 μM),
added automatically using pump to release remaining ATP. Panel
b and c show the values of released and remaining ATP in Capan-1
and AR42J cells, respectively. These values were calculated per cell
after 1, 12 min and 24 h (n = 8, 7, 10 and n = 5, 5, 10) of incubation
with CDCA. Data are shown as mean values ± SEM; ***= P < 0.001,
N.S. - not significant
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perfused with a buffer containing 5 mM Na+, which
favours Ca2+ influx via NCX as observed in Fig. 9c. This
effect of low Na+ on [Ca2+]i was increased with GPBAR-
A (30 μM), which is consistent with TGR5 stimulation
of NCX.
Discussion
The present study shows that some of the BA (i.e.,
CDCA) effects are due to stimulation of purinergic sig-
nalling. Firstly, acini and ducts (AR42J and Capan-1
cells) release substantial amounts of ATP in response to
CDCA, and this process can be inhibited by several
inhibitors of ATP release. Secondly, CDCA effects on
intracellular Ca2+ could be significantly inhibited by P2
receptor antagonists, indicating cross-activation of the
two signalling pathways. Furthermore, the TGR5 recep-
tor affected intracellular Ca2+ indirectly by activating
NCX. Below, we discuss these results and propose that
interplay between BAs and purinergic signalling may be
important in physiological regulation of pancreatic
function.
In order to evaluate physiological or pathological ef-
fects of BAs, it is important to consider what BAs con-
centrations pancreas may encounter. In healthy human,
plasma BAs concentrations are <5 μM in resting state
and about 10–15 μM post-prandial. However, in case of
liver or pancreatic diseases, BAs concentrations can in-
crease to around 300 μM [48, 49]. In normal bile, the
concentration of bile acids is higher than 100 mM, and
CDCA contributes to about 50 % [50]. Therefore, pan-
creas could be exposed to low BA concentrations as well
as to higher concentrations resulting from bile reflux
into pancreatic duct tree following outflow obstruction,
e.g., gallstones. In the current studies, we used concen-
trations that have been considered stimulatory on pan-
creatic ducts [27, 28].
The most important finding is that primary bile acids
can cause ATP release and therefore stimulate purinergic
signalling in exocrine pancreatic cells. The unconjugated
CDCA had the most pronounced effects compared to far
less effective glycine- and taurine-conjugated forms of the
acid (Fig. 1). Thus CDCA caused fast and large ATP re-
lease from both acinar and duct cells (Fig. 1). In com-
parison, cholinergic or hormonal stimulation or cell
swelling of pancreatic cells induced significantly lower
ATP release [34, 35]. We investigated the mechanisms
of ATP release and find that both exocytotic pathways
and ion channels/receptors seemed to be involved in
this process (Fig. 2b, c). Our findings with bafilomycin,
brefeldin and NEM strongly support participation of a
vesicular component in ATP release, e.g., VNUT
(Fig. 2b), which is also expressed in duct cells (unpub-
lished data). In addition, the inhibitor data (Fig. 2C) in-
dicate that connexin hemichannels and/or pannexin
with P2X7R could also be involved in ATP release. One
of the most potent blockers was Gd3+ that can inhibit
pannexin/connexins, Ca2+ influx and hence exocytosis,
and it is known inhibitor of maxi-anion channels which
may be a part of osmosensitive ATP release with hypo-
tonic stress [51, 52]. We cannot exclude that CDCA either
can activate these maxi-anion channels directly or it in-
duce cell volume changes, though cell volume changes
due to hypotonic shock (unpublished data) have much
smaller impact on ATP release than CDCA. The P2X7 re-
ceptors may also have positive effects on CDCA-induced
ATP release (Fig. 2c), and modulating effects of the recep-
tor on exocytosis and/or pannexin-1 have been described
in other cells [53, 54]. CFTR has also been proposed as a
channel/regulator for ATP release [36] and in bile ducts
the secondary ursodeoxycholic acid stimulates CFTR-
dependent ATP secretion [43]. In Capan-1 cells, CFTR
does not seem to contribute to ATP release (unpublished
Fig. 6 Effect of CDCA and ATP on [Ca2+]i responses in perfused and
non-perfused conditions in Capan-1 cells. Representative recordings
of intracellular Ca2+ concentrations [Ca2+]i in Capan-1 cells in perfused
and non - perfused (standing bath) conditions. a A chamber with
Capan-1 cells was perfused (1 ml/min) with physiological buffer
containing 0.3 mM CDCA or 100 μM ATP. b Addition of CDCA to a
standing bath showed delayed response to CDCA and diminished
[Ca2+]i response induced by ATP (100 μM). c and d show the summary
of data as mean values ± SEM, (n = 5, 4)
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data). Taken together, we propose that several ATP
releasing mechanism contribute to CDCA-evoked ATP
release, and result in extracellular ATP increase by 100–
1000 fold, which is the largest increase compared to that
observed with other stimuli (unpublished data).
One important point to consider was how the BA-
induced ATP release is triggered. Since GPBAR-A and
GW4046 had no effects on ATP release, we presume
that the TGR5 and FXR receptors are not involved. An
alternative mechanism could be BA induced membrane
depolarisation [21], which may be mediated by activation
of bile acid-sensitive ion channel (BASIC), which belongs
to the DEG/ENaC family, recently identified in bile ducts
[55]. In addition, CDCA may incorporate into mem-
branes, increase membrane fluidity [56] and thereby affect
one or more of ATP release mechanisms as proposed
above. Nevertheless, we show that the ATP release is
clearly directed towards the lumen of pancreatic ducts
(Fig. 2a), and therefore it is likely that there is a trigger
mechanism and luminal exocytosis/transport mechanisms.
Also in other epithelia, e.g., kidney tubuli and airway epi-
thelia, ATP is released preferentially to the apical/luminal
side in response to a number of stimuli [57–60].
Regarding effect of BA in pancreas, we propose that
BA stimulates release of ATP towards lumen and then
ATP binds to P2 receptors and therefore stimulates Ca2+
signalling pathways, and these can potentially increase
Cl− and K+ conductances, which are necessary to initiate
and acid/base transport and thus ductal fluid secretion.
Indeed it is well documented that several P2 receptors
regulate ion channels such as TMEM16A/ANO1, CFTR
and KCa3.1 and KCa1.1 [32, 61]. The more traditional
view is that BAs acting directly on BA receptors can
affect epithelial transport [10, 26, 62]. For example, in
airway epithelial cells, taurodeoxycholic acid (TDCA)
stimulates CFTR and Ca2+-activated Cl− currents and
these effects seems to be mediated by the basolateral
TGR5 receptor [10]. From published studies on pancre-
atic duct epithelia, it was not clear whether BA receptors
were expressed. Nevertheless, it is reported that in dog
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Fig. 7 Effect of P2 receptor inhibitors on intracellular Ca2+ responses induced by CDCA in Capan-1 cells. a and b Representative recordings of
[Ca2+]i transients in Capan-1 cells with or without P2 receptors inhibitors (standing bath). Cell were incubated with a mix of P2R inhibitors: PPADS
(250 μM), suramin (250 μM), and 10 μM of AZ 10606120 and 10 μM of A438079 for 25 min. a, c The presence of P2R antagonists markedly inhibited
[Ca2+]i response induced by ATP (100 μM), but had no effect on Thapsigargin (1 μM) induced Ca2+ response. b, d Incubation cells with P2R antagonists
inhibited [Ca2+]i transient induced by 0.3 mM CDCA but not by Thapsigargin (1 μM). c, d Change in [Ca2+]i above baseline are given as mean values ±
SEM of 7–15 cells per each independent experiment (n). Arrows indicate the time of adding the stimuli. *= P< 0.05, ***= P< 0.001, N.S = not significant
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pancreatic duct epithelial cells TDCA also increased Cl−
and K+ fluxes [26], and in guinea pig pancreatic ducts
BAs stimulate KCa1.1 channels, but accompanying Cl
−
channels have not been detected [27, 30].
Previous studies show that CDCA (0.5 mM) caused
ATP depletion in pancreatic acinar cells and colon epi-
thelial cells, presumed to be due to inhibited metabolism
[63, 64]. Since CDCA induced such a large ATP release
in our exocrine cells (Fig. 1), it was relevant to examine
whether CDCA could also affect intracellular ATP. We
have used several techniques to study this, including
intracellular ATP sensors. The transient increase in
MgGreen fluorescence could indicate transient decrease
in ATPi. However, since CDCA and ATP caused transi-
ent increase in [Ca2+]i, and the fluorophore can also
bind Ca2+, the MgGreen signals can have several com-
ponents. In addition, in AR42J cells there was a slow
increase in MgGreen fluorescence occurring long after
Ca2+ peak. There was a similar slow effect of CDCA on
AT1.03YEMK ratio, as well as a change in the lifetime
constants of the sensor. These data together indicate
that there was a decrease in ATPi. Using luciferase assay,
we find that in the first minute after CDCA stimulation
acinar cells release significant amount of cellular ATP
(Fig. 5c), though ATPi seems to decrease first after
12 min, as also indicated by the AT1.03YEMK measure-
ments (Fig. 4). Nevertheless, it is only after long-term in-
cubation of AR42J cells with 0.5 mM CDCA that
significant depletion in ATPi was detected by lumines-
cence assay (Fig. 5c). This depletion could be due to de-
creased mitochondrial ATP production and/or secondary
effects caused by digestive enzymes released by CDCA-
induced exocytosis [20, 63, 65] and by exocytosis/release
of ATP, as we show in the present study. In contrast to
acini, pancreatic ducts seem very robust. In duct cells,
CDCA caused release of less than 3 % of total intracellular
ATP, and ATP was presumably replenished (Fig. 5b),
which also agrees with total recovery of MgGreen fluores-
cence with continued CDCA stimulation. Interestingly, in
pancreatic islets, BAs (e.g., tauroursodeoxycholate) are not
detrimental but enhance ATPi concentration [15].
It is extensively documented that BAs (0.1 – 1 mM)
cause an increase in [Ca2+]i in many cells, including
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e. The effect of the TGR5 receptor agonist GPBAR-A at 3 and 30 μM
(n = 3, 4) on ATP release from Capan-1 cells. f Expression of FXR in
Capan-1 cells showed by RT-PCR. Activation of FXR with the specific
agonist GW4046 at 0.1 and 1 μM (n = 3, 2) did not have effect on ATP
release from duct cells. Arrows indicate when the agonists were added
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pancreatic cells and mechanisms include increased re-
lease from ER, inhibition of SERCA and increased Ca2+
entry [20, 21, 27, 66]. Regarding TGR5, it is well estab-
lished that the receptor interacts with Gs protein and
leads to stimulation of adenylate cyclase and cAMP sig-
nalling [5, 12, 45, 67]. In addition, several reports show
that BAs (high μM concentrations) show small and slow
increases in intracellular Ca2+ [10, 18, 21, 23, 25, 45].
Underlying mechanisms are unclear, as seen in a number
of studies, though one study has suggested the involve-
ment of TGR5 [10, 18, 21, 23, 25, 45]. In pancreatic acinar
cells genetic deletion of TRG5 still leaves BA-induced
Ca2+ transients in many cells and BA-stimulated amyl-
ase release is relatively undisturbed [25], indicating that
there is not very tight coupling between TGR5 and Ca2+
signalling. Since GPBAR-A had no effect on [Ca2+]i in
our duct cells expressing the receptor, it seems that
TGR5 receptor is not involved in initiating simple Ca2+
transients in given experimental conditions. We propose
that CDCA-evoked ATP release leads to P2 receptor acti-
vation and thereby increases in [Ca2+]i. Indeed, CDCA-
stimulated Ca2+ increase was inhibited by a cocktail of
P2R antagonists (Fig. 7d). This observation indicates
that a significant part of Ca2+-dependent BA effects
could be due to ATP release and subsequent stimulation
of P2 receptors expressed in duct cells. These processes
and potential effects on ion transport are acute (seconds
to minutes). Our study did not address the question
whether BAs via activation of FXR and TGR5 could
regulate purinergic receptor expression on a longer
time-scale.
The differences in the thapsigargin induced Ca2+ re-
sponse after stimulation with ATP or CDCA lead us to
speculate whether there is a possible protective role of
CDCA during high [Ca2+]i stress conditions in pancreas.
It has been shown that CDCA can protect cells when ER
is depleted of Ca2+ [68]. We observed that CDCA mark-
edly decreased the thapsigargin-induced high [Ca2+]i and
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Fig. 9 Effect of the TGR5 ligands on [Ca2+]i transients in duct epithelia. Capan-1 cells were incubated with nominal 0 mM Ca
2+ buffer (a, b) and
thapsigargin (1 μM) to deplete intracellular Ca2+ stores. Thereafter, cells were gently perfused with physiological buffer to refill intracellular Ca2+
stores and after the fluorescence was relatively stable, solutions were changed to GPBAR-A (30 μM), CDCA (0.3 mM), or control. c, d The contribution
of the sodium-calcium exchanger (NCX) was tested. Cells were perfused with 5 mM Na+ buffer which increased [Ca2+]i and this response was
potentiated in the presence of GPBAR-A (30 μM). b, d Summary of data given as mean values ± SEM of 7–15 cells per each independent experiment
(n). *= P< 0.05, ***= P< 0.001, N.S = not significant
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that the GPBAR-A was similarly effective (Fig. 9a).
Others have shown that bile acids could prevent
thapsigargin-evoked ER stress in liver, adipocytes and β-
cells [15, 69]. Our observations are in the line with these
and we suggest that the “protective effect” of CDCA is
mediated via TGR5 activation. Pancreatic ducts express
NCX, which is stimulated by cAMP and Ca2+ [47]. We
propose that some of the CDCA-induced decrease in
high [Ca2+]i conditions could be due to NCX activation.
Indeed stimulation of TGR5 with GPBAR-A increased
NCX activity (Fig. 9c). It should be noted that since
NCX is electrogenic (exchanging 1 Ca2+ : 3 Na+), it can
transport Ca2+ in or out of the cell, depending in elec-
trochemical potential, and this could vary depending on
the cell type and its stimulation.
Conclusions
In conclusion, as summarized in Fig. 10, the most im-
portant finding in our study is that unconjugated BA
evokes significant ATP release from pancreatic exocrine
cells, this ATP in turn can stimulate P2R, which thereby
increases [Ca2+]i. We show the expression of the TGR5
receptor in a human duct cell line, where it could play
a protective role at high intracellular Ca2+ conditions.
Taken together, for pancreas we envisage that purinergic
signalling is a significant part of the cellular response to
BA and could support the physiological function such as
secretion. Finally, we propose that purinergic signalling,
i.e., ATP release and cell/organ P2 receptor involvement,
should be taken into consideration in other cell/organ
types, as it could potentially explain the multifaceted
and ubiquitous effects of BAs.
Methods
Chemicals
All chemicals were purchased from Sigma-Aldrich unless
otherwise specified. In present study following chemicals
were used: chenodeoxycholic acid (CDCA sodium salt,
0.1 – 1 mM), glycochenodeoxycholic acid (GCDCA so-
dium salt, 0.3 and 1 mM), taurochenodeoxycholic acids
(TCDCA sodium salt, 0.3 and 1 mM), ATP (100 μM),
digitonin (50 μM), thapsigargin (1 μM), 4-[[3,5-Bis
(trifluoromethyl)phenyl]methyl]-6-(2-fluorophenyl)-4,5-
dihydro-pyrido[3,2-f]-1,4-oxazepin-3(2H)-one (GPBAR-
A, 30 μM, Tocris) dexamethasone (50 nM). Cells were
pre-treated/incubated with inhibitors and fluorescent
indicators as follow: bafilomycin A1 (1 μM), N-Ethyl
maleimide (NEM, 250 μM), brefeldin A (5 μg/ml;
Fig. 10 Proposed model of CDCA-induced cellular responses in pancreatic duct cells. CDCA acting on the plasma cell membrane induces ATP
release via non-vesicular releasing mechanisms (pannexin, connexin, P2X7R, other ion channels) and vesicular exocytosis of ATP. Released ATP
may in turn activate P2X receptors/cation channels and P2Y receptors, which allow Ca2+ influx directly (P2XR) or via G-protein coupled signalling
mediate Ca2+ release from intracellular stores and Ca2+ influx (P2YR). Furthermore, CDCA may activate TGR5 receptor, which leads to stimulation
of adenylyl cyclase and cAMP production, possibly increase in Ca2+ in some cells by yet undefined mechanisms. The sodium-calcium exchanger
(NCX) can be stimulated by TGR5 resulting of transport of Ca2+ out of the cell, or into the cell, depending on prevailing electrochemical gradients
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Molecular Probes- Life Technology), pannexin inhibitor
10Panx (100 μM, Tocris), gadolinium chloride (Gd3+,
50 μM), probenecid (500 μM), P2X7 inhibitors:
AZ10606120 (10 μM, Tocris) and A438079 (10 μM,
Tocris), pyridoxal phosphate-6-azo(benzene-2,4-disulfonic
acid) tetrasodium salt hydrate (PPADS, 250 μM), suramin
250 μM, Magnesium Green indicator (MgGreen; 5 μM,
Invitrogen), Fura-2 AM calcium indicator (5 μM, Teflabs),
pluronic F127 (Molecular Probes- Life Technology), ATP
kit SL 144–041 (BioThema), cell counting kit-8 (CCK-8,
DOJINDO).
Cell cultures
Pancreatic rat acinar (AR42J, CRL-1492) and human
duct (Capan-1, HTB-79) cell lines were obtained from
ATTC (Manassas, VA) and cultured according to recom-
mended procedures. For imaging experiments WillCo-
dishes (WillCo Wells BV, Amsterdam, the Netherlands)
were used and for luminescence, 96-well NUNC white
plates. For luminescence recordings of ATP release,
50,000 Capan-1 cells were cultured to 80 % confluence
and for imaging 35.000 cells were cultured for 2 days.
For all experiments for AR42J, 10,000 cells (or 40,000
cells for FRET-FLIM analysis) were plated and grown for
48 h, followed by 48 h with 50 nM dexamethasone to in-
duce an acinar phenotype, which increases formation of
zymogen granules [70]. All experiments were conducted
at 37 °C.
Measurement of ATP concentrations
Different protocols were used to measure ATP: in extra-
cellular fluid; in single cells; permeabilized cells and
polarized cells. Extracellular ATP (ATPe) was monitored
in using luciferase + luciferin luminescence reaction in
extracellular medium. Capan-1 and AR42J cells were
washed and allowed to rest in 65 μl of physiological buf-
fer that contained (in mM): 140 NaCl, 1 MgCl2 · 6H2O,
1.5 CaCl2, 0.4 KH2PO4, 1.6 K2HPO4 · 3H2O, 10 HEPES
and 20 glucose (Capan-1) or 10 glucose (AR42J); pH =
7.4. After 30 min, 25 μl of 2 × concentrated luciferase/
luciferin mix was added into the wells. Measurements
were made using plate mode (20-s sampling rate with
1-s integration) in FLUOstar Optima (BMG, Labtech).
CDCA (10 μl) was gently added manually. To quantify
CDCA-induced intracellular ATP (ATPi), similar proto-
col was repeated but after 1 min of recordings, cells
were permeabilized with 25 μl of digitonin (50 μM). For
each experimental protocol, standard curves were made
with ATP concentrations 10−9 to 10−5 M. The bile acids
were included in all standards. Also the effect of the in-
hibitors on luciferase/luciferine was tested independently
on standard curves (Additional file 1: Figure S2 a-b). Cell
number was determined by cell counting kit and ATP
concentrations were corrected for 106 cells per 1 ml. To
calculate the single cell ATPi concentration, volumes of
Capan-1 and AR42J were estimated assuming a spherical
shape with diameter of 12 μm and 10 μm, respectively.
To investigate the polarity of ATP release, i.e., to the
luminal or basolateral sides of polarized epithelium,
200,000–400,000 Capan-1 cells/cm2 were seeded on
collagen-coated Snapwells (no. 3407; Corning). When
resistance of the monolayer was ~ 500–600 Ω*cm
2,
Snapwells were put into a holder, and monolayers were
incubated with 500 μl of physiological solution on each
side (luminal and basolateral). 150 μl of fluid was col-
lected for a baseline value, and cells were then luminally
or basolaterally stimulated with 0.3 mM CDCA. 150 μl
samples collected from apical and basolateral sides and
heated for 1 min in 98 °C and kept on ice before ana-
lysed for ATP.
Magnesium-Green fluorescence measurement
ATPi was estimated indirectly using Magnesium Green
(MgGreen) fluorescence. Cells were incubated with
5 μM MgGreen in presence of 0.02 % pluronic F127 for
20 min and gently washed 15 min before experiments.
MgGreen was excited with an argon laser (488 nm) and
emission was monitored at 498–581 nm using a con-
focal laser scanning microscope (TCS SP 5X, Leica
Microsystems, Heidelberg). Images were captured every
3 sec using a 20X N.A. 0.7 immersion (water) objective.
Images analysis was performed on 10 single cells or
group of AR42J per dish. Changes of ATPi responses are
presented as ratios at time t in relation to time 0 (Ft/F0)
and baseline is set to 1.
ATP sensor FRET-FLIM microscopy
ATPi was estimated more specifically using FRET sensor
based on ε subunit of bacterial F0F1-synthase, i.e.,
AT1.03YEMK [41]. AR42J cells were transfected using
FuGENE transfection kit (Promega) according to manu-
facturer’s protocol. Media was changed the day after
transfection to media containing dexametasome. Exper-
iments were conducted on AR42J cells bathed in
physiological saline containing 10 mM glucose and the
temperature was 37 °C and images were collected with a
63 x water objective (HCX PLAPO, 1.2 NA) in a TCS
SP5X Confocal microscope). Two types of recordings were
made: FRET ratio analysis and FRET-FLIM analysis. In
time resolved protocols, 405 nm laser was used for excita-
tion of the CFP, the fluorescence of CFP and excited YFP
was collected simultaneously at 460–500 nm for CFP and
530–570 nm for YFP. Images were taken at 3 s intervals.
The individual measurements were corrected for back-
ground and YFP/CFP ratio was continuously recorded. In
separate experiments, FRET was estimated using fluores-
cence lifetime imaging (FLIM). The SP5X microscope,
equipped with a time-correlated single-photon counting
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(TCSPC) module (PicoHarp 300, PicoQuant, Berlin,
Germany), allows FLIM analysis using a Mai-Tai Ti-
Sapphire laser (850 nm) providing 80 ps pulses. The
CFP lifetime was recorded with the emission filter:
450–500 nm and detected by FLIM PMT. The laser
power was reduced so the counting was kept under 800
kcounts to avoid build up effects. Photons were col-
lected continuously for 2 min for each image. The decay
curve was analysed with the SymProTime software
(PicoQuant) via a tail-fitting procedure. The counts
around the peak were typically around 103 photons and
the quality of the fit was judged on the basis of the chi-
squared statistic, χ2, and reduced randomness of resid-
uals. Three to five different positions in each dish with
cells were analysed before and after addition of CDCA.
Calcium signals
Capan-1 cells were incubated with Fura-2 AM in the
presence of 0.02 % pluronic F127 and probenecid
(0.25 mM) in physiological buffer for 30 min. For perfu-
sion experiments the perfusion rate was 1 ml/min. For
standing bath (non-perfused) conditions cells were incu-
bated for 25 min with or without P2R antagonists. In
some experiments, Capan-1 cells were stimulated with
Thapsigargin in nominal Ca2+-free buffer containing (in
mM): 115 NaCl, 25 Na-gluconate, 1 MgCl2 · 6H2O, 5
HEPES, 1.6 K2HPO4 · 3H2O, 0.4 KH2PO4, 20 glucose, 5
EGTA. Subsequently, cells were gently perfused with
buffer containing Ca2+ and after 6–8 min cells were per-
fused with physiological buffer including CDCA or
GPBAR-A. In order to examine the role of the sodium-
calcium exchanger (NCX) on [Ca2+]i changes, Capan-1
cells were perfused with 5 mM Na+ buffer, where the
rest of NaCl was substituted with 140 N-Methyl-D-Glu-
camine (NMDG) titrated with HCl. Fura-2 recording
was performed on a system described earlier [71]. Fura-
2 ratios were calibrated in situ to calcium concentrations
based on formula described by Grynkiewicz [72] with Kd
for Fura-2: 224 nM.
Reverse transcription PCR
RNA was isolated using RNeasy Mini Kit (Qiangen
74104) following the manufacturer’s instructions. RT-
PCR was analysed with QIAGEN OneStep RT-PCR Kit
(210212) with amplification parameters as follows: one
cycle at 50 °C for 30 min and one cycle at 95 °C for
15 min followed by 37 cycles at 95 °C for 30 s, 58 °C for
30 s, 72 °C for 40 s, and one final cycle at 72 °C for
10 min. The following primers were designed using
Primer BLAST and used for TGR5 amplification: human
TGR5 forward 3′ TCCTGCCTCCTCGTCTACTT 5′
human TGR5 reverse 3′ GGTAGGGGGCTGGGAAG
ATA 5′(247 bp), human FXR forward 3′AGAGATGGG
AATGTTGGCTGAA 5′ human FXR reverse 3′ GTGA
GTTCAGTTTTCTCCCTG 5′(186 bp), rat TGR5 for-
ward 3′ GCTACTGGAGTGGTAGGCAG 5′ rat TGR5
reverse 3′ TCAGTCTTGGCCTATGAGCG 5′(225 bp).
All primers were synthesised by TAG Copenhagen A/S
(Denmark).
Western blot
Protein lysates were prepared by adding lysis buffer
(50 mM TrisBase, 0.25 M NaCl, 5 mM EDTA, 1 %
Triton X-100, and 4 mM NaF) containing protease
inhibitor. Cell lysates were centrifuged at 15,000 g
for 15 min at 4 °C. To obtain the membrane microdo-
main enriched samples the lysate was centrifuged at
200,000 g for 1 h (Beckman Ultracentrifuge Ti 70.1
Rotor) [61]. Western blot samples were denatured by
heating to 37 °C in 50 mM dithiothreitol for 30 min
and run on precast gels from Invitrogen. The mem-
branes were blocked overnight at 4 °C in 0.5 % milk
powder and 1 % BSA. Primary antibody for TGR5
(1:400 rabbit, Abcam ab72608) were added in blocking
buffer for 1.5 h. The goat anti-rabbit secondary anti-
body conjugated to horse-radish peroxidase (1:2.500)
was added in blocking buffer, for 1 h. EZ-ECL chemilu-
minescence detection kit for HRP (BI, Biological In-
dustries) was added and blots were viewed on Fusion
FX Vilber Lourmat.
Immunocytochemistry
AR42J cells were grown on glass coverslips (similar as
for dishes, see above) and Capan-1 cells were seeded on
collagen coated Snapwells. The cells were gently washed
with physiological PBS and fixed in 4 % paraformalde-
hyde in PBS for 15 min, treated with 0.1 M TRIS-glycine
(pH 7.4) for 15 min, and then rinsed in PBS and perme-
abilized for 10 min in PBS with 0.5 % TritonX-100. Cells
were blocked with 10 % BSA in PBS for 45 min and then
incubated with TGR5 (1:400; Abcam) for 1.5 h. Slides
were washed for 10 min and then incubated 1 h with
1:400 goat anti-rabbit secondary antibody conjugated to
Alexa 488 (Life Technology). For nuclear staining, DAPI
was used (1:400) and mounted with DAKO fluorescent
mounting medium. Slides were viewed using a 40X N.A
1.3 objective with TCS SP 5X.
Statistics
Data are shown as the mean values ± S.E.M. To test the
statistical significance between two conditions, unpaired
two-tail Student’s t test was applied. For multiple condi-
tions, one-way ANOVA with Bonferroni’s Multiple
Comparison Test was used. P < 0.05 was considered sta-
tistically significant. For FLIM-FRET analysis and statis-
tics see above.
Kowal et al. Cell Communication and Signaling  (2015) 13:28 Page 14 of 16
Additional file
Additional file 1: Figure S1. Effect of GPBAR-A on intracellular Ca2+
response from Capan-1 cells. Figure S2. Effect of (A) CDCA and (B) ATP
release inhibitors on standard curves.
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